Thursday, December 17, 2009

Hepatitis D More Condition_symptoms Why Is Hepatitis B More Of A Concern Then Hepatitis A, C, D And E?

Why is Hepatitis B more of a concern then Hepatitis A, C, D and E? - hepatitis d more condition_symptoms

Hepatitis B causes acute and chronic hepatitis in some patients who are not able to eliminate the virus. Identified methods of transmission include blood (blood transfusion, now rare), tattoos (both amateur and professional will be done)) horizontally (sexually or through contact with blood or body fluids) or vertically (from mother at birth son. However, the source can be determined by about half the cases of the infection. Blood contact can occur through the sharing of intravenous injections of drug use, shaving accessories such as razor blades, or touching wounds infected persons. The sharing of needles and in many countries, developed as a form of prevention. In the United States, 95% of patients develop clear their infection and development of antibodies against hepatitis B. 5% of patients do not eliminate the infection and chronic infection, and only those people at risk of long-term complications of hepatitis B are

Insufficient patients with chronic hepatitis B have antibodies against hepatitis B, but these antibodies to remove the infection that set in at thand DNA affected by liver cells. The continued production of virus combined with antibodies is considered a likely cause of immune complex disease in these patients. A vaccine that prevents infection with hepatitis B infection with hepatitis B by 500,000 to 1,200,000 deaths per year worldwide due to complications of chronic hepatitis, cirrhosis and hepatocellular carcinoma. Hepatitis B is endemic in several countries (notably South East Asia), the murderer of liver cirrhosis and hepatocellular carcinoma big. There are three FDA-approved treatment options for people with chronic infection with hepatitis B: interferon alfa, lamivudine and adefovir. In about 45% of respondents in the treatment is a sustained response.

0 comments:

Post a Comment